Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Euro Q2 Consumer Health Earnings Preview: Volatility, Delay, Upturn And Goodbye

Jul 18 2022

• By Tom Gallen

Q2 written on a speechbubble — • Source: Shutterstock

Related Content

EU Business News: Haleon Launch Date Set, BioGaia Pens Korea Deal, Revive Active Gets Investment

Jun 14 2022

Reckitt Restructure Seeks To Maximize Dietary Supplement Growth

Feb 22 2022

Chr. Hansen Flags Challenging Outlook For Probiotic Supplements Market

Jul 12 2022

US Q2 Consumer Health Earnings Preview: Horizon Brightens Beyond Current Questions, Challenges?

Jul 18 2022

Reckitt's Q1 VMS Results Exceed Expectations Driven By Sales In China

May 02 2022

Sanofi Starting US Cialis OTC Actual Use Study Soon While Tamiflu Switch Progress Delayed

Apr 29 2022

GSK Achieves Strong Sales Growth In Q1 Despite Cost Of Living Pressures On Consumers

Apr 27 2022

Bayer Sees Increased Demand Across All Consumer Health Categories In Q1

May 11 2022

Delay For Sanofi’s OTC Cialis Study In US Could Be Sign of Hurdles Holding Back Other Switches

May 31 2022

Sanofi Counts On OTC Switches Adding $1bn In Consumer Revenues By 2026

Dec 12 2019

GSK Highlights E-Commerce Gains As Sales Growth Returns

Jul 29 2021

Reckitt Sees Positive Signs For Cold & Flu Brands After Difficult First Half

Jul 28 2021

Sanofi's Focus On Priority Categories Bears Fruit In Second Quarter

Jul 30 2021

Bayer Raises Consumer Health Guidance Following Double-Digit Gain In Q2

Aug 06 2021

Additional Topics

Europe Business Strategies Dietary Supplements OTC Drugs Sales & Earnings Consumer

More from Europe

More from Geography

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window